ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
Feb 28, 2020 20:00 JST
Source:
HY Medical
HY Medical AI and You'an Hospital join forces in the battle against NCP
BEIJING, Feb 28, 2020 - (ACN Newswire) - Professor Li Hongjun, Chairman of the Professional Committee of Infectious Disease Radiology of the Chinese Medical Association Radiology Branch and Director of the Department of Radiology of You'an Hospital, along with members of the committee worked through the Spring Festival holidays, racing against time to launch the first "Handbook of Medical Imaging Diagnosis of NCP" (English and Chinese Edition). Under the leadership of Director Li Hongjun, You'an hospital continues to fight the battle to defend the public health. Recently, HY Medical's NCP AI imaging intelligent solution has been stationed in You'an Hospital, bringing practical intelligent assistance to the complete process of screening, diagnosis and treatment of the NPC epidemic.
HY Medical: How will AI join forces in the battle against NCP?
The coronavirus infection, also known as COVID-19, hit with a relentless fury since its initial outbreak in Wuhan, China. As of Feb 24, 2020, there have been 2,000 reported deaths out of 70,000 infected so far.
Medical imaging plays a crucial role in the diagnosis and treatment of Novel Coronavirus Pneumonia (NCP), from early discovery of lung abnormalities in suspect cases, to confirming diagnosis and/or determining level of progression, from excluding suspect cases through differential diagnosis, to forming and adjusting treatment plans, as well as tracking conditional development and evaluating the final treatment efficacy and outcome.
"Real" AI for real assistance, Fight the epidemic hand in hand
Starting with the algorithm, the HY Medical team collected large amounts of NPC data in real time and obtained precise labelling from a professional panel of doctors to use as the base for their deep learning algorithm. The HY Medical AI system automatically adapts to images from different hospitals, different equipment, and different layer thicknesses, as well as apply self-iteration and model optimizations. The detection and accuracy rate of NPC lesions have reached 96%; combined with technologies such as efficient processors and lightweight network models, it only takes 2-3 seconds to process a CT study with 500 images.
According to on-site personnel, "CT data is but a collection of values used to describe density, CT values alone will not help in determining the various types of indicators in data. Selecting precise labeled data + deep learning algorithm can help demarcate each individual lesion, providing precise contour and volume. AI products play a key role in assisting doctors with their diagnosis, its ability to accurately pin-point the position and identify lesions is of great value in clinical practice."
About HY Medical
As a leading AI medical imaging company, HY Medical, through advanced technologies such as artificial intelligence and big data analysis, and leveraging SaaS services on the cloud, HY Medical solves data standardization, centralized storage, information interoperability, and various scenario based applications that can scale. The AI-assisted clinical diagnosis and treatment applications cover diagnosis and screening for more than ten diseases in addition to NCP, as well as support digital e-films applications and big data research applications.
Contact:
HY Medical
Person: Wendy Jia
Email:
jiajingwen@huiyihuiying.com
/
marketing@huiyihuiying.com
Website:
http://en.huiyihuiying.com/
Source: HY Medical
Sectors: Healthcare & Pharm
Copyright ©2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Latest Release
Mazda Production and Sales Results for August 2024
Sep 27, 2024 17:20 JST
Honda Issues Integrated Report - "Honda Report 2024"
Sep 27, 2024 15:37 JST
Hitachi Becomes First Oracle Partner in Japan to Win Regional Best in Class Award in the Customer Success Category in the 2024 Oracle Partner Awards
Sep 27, 2024 14:19 JST
Mitsubishi Corporation Strengthens the Partnership with PETRONAS, Reinforcing Confidence in LNG Operations in the Region
Sep 27, 2024 13:39 JST
MHI Completes Production of the Core Stage of the Final H-IIA Launch Vehicle (No. 50)
Sep 26, 2024 12:00 JST
A2Z and Nayax Capital Sign Framework Agreements to Enable Global Financing for the Sale or Lease of Cust2Mate Smart Carts Integrated with Nayax's Solutions
Sep 25, 2024 22:00 JST
Osaka Gas and MHI to Implement the CO2NNEX Digital Platform for Managing and Transferring the Environmental Value of e-Methane at Expo 2025 Osaka, Kansai, Japan
Sep 25, 2024 15:11 JST
Hitachi Rail Unveils the 'HMAX' AI Solution, Accelerated by NVIDIA, to Optimize Trains, Signaling and Infrastructure
Sep 25, 2024 13:05 JST
Overview of Honda Exhibits at JAPAN MOBILITY SHOW BIZWEEK 2024
Sep 24, 2024 18:32 JST
Tosha Schareina Wins FIM E-Xplorer World Cup Men's Category
Sep 24, 2024 18:16 JST
Mazda to open new R&D office in Azabudai Hills in early summer 2025
Sep 24, 2024 16:25 JST
Rozebalamin(R) for Injection 25 mg (Mecobalamin) Approved in Japan for Amyotrophic Lateral Sclerosis
Sep 24, 2024 16:06 JST
Valuufy CEO to present at the UN Science Summit (SSUNGA79)
Sep 24, 2024 16:00 JST
Anticancer Agent "Tasfygo(R) Tablets 35mg" (Tasurgratinib Succinate) Approved in Japan for Biliary Tract Cancer with FGFR2 Gene Fusions or Rearrangements
Sep 24, 2024 15:01 JST
Mitsubishi Corporation, KDDI CORPORATION, Lawson, Inc. Launching an Initiative to Transform into "Next-generation Convenience Store"
Sep 20, 2024 18:02 JST
Hitachi Rail is innovating and delivering transformative 5G digital signalling
Sep 20, 2024 16:47 JST
Olympus Launches New 4K Camera Head for Urological Endoscopy
Sep 20, 2024 15:00 JST
Honda to Relocate the Base of its Rugby Team Activities
Sep 19, 2024 15:05 JST
Renewal of Compact CO2 Capture System "CO2MPACT(TM)" Series
Sep 19, 2024 14:35 JST
The world's first commercial copper die-cast rotor for railway traction motors
Sep 19, 2024 13:57 JST
More Latest Release >>